Ghodsizad Ali, Singbartl Kai, Loebe Matthias, Zeriouh Mohamed, Ruhparwar Arjang, Grant April, El-Banayosy Ali, Koerner M M
Miami Transplant Institute, University of Miami, Jackson Memorial Hospital, Miami, Florida, USA.
Heart and Vascular Institute, Penn State Milton S. Hershey Medical Center, Penn State College of Medicine, Hershey, Pennsylvania, USA.
Heart Surg Forum. 2017 Dec 22;20(6):E274-E277. doi: 10.1532/hsf.1635.
Mechanical circulatory support can prevent multi-organ failure and death in patients with advanced cardiogenic shock. Here we describe our experience using extracorporeal membrane oxygenation (ECMO) for treatment of advanced cardiogenic shock which has been used by our team for daily routine care in more than 200 patients during the last five years at the Penn State Medical Center. Venoarterial (VA) ECMO has been used as a viable therapeutic option for advanced cardiogenic shock as a bridge to recovery (BTR) or bridge to next decision (BTD). Our group performed a retrospective review of data from 155 patients from our single center cohort treated with VA ECMO for advanced cardiogenic shock. After successful ECMO treatment, the one year survival rate of patients with ischemic heart disease was 73.7 %, and the one year survival for patients with non-ischemic heart disease was 75%.
机械循环支持可预防晚期心源性休克患者发生多器官功能衰竭和死亡。在此，我们描述我们使用体外膜肺氧合（ECMO）治疗晚期心源性休克的经验，在过去五年中，我们团队在宾夕法尼亚州立大学医学中心已将其用于200多名患者的日常护理。静脉-动脉（VA）ECMO已被用作晚期心源性休克的一种可行治疗选择，作为恢复的桥梁（BTR）或下一个决策的桥梁（BTD）。我们小组对来自我们单中心队列的155例接受VA ECMO治疗晚期心源性休克的患者的数据进行了回顾性分析。在成功进行ECMO治疗后，缺血性心脏病患者的一年生存率为73.7%，非缺血性心脏病患者的一年生存率为75%。
